{
    "__type__": "Deck", 
    "children": [], 
    "crowdanki_uuid": "0aecb5c0-d637-11e7-8582-408d5c5c9416", 
    "deck_config_uuid": "0aecb5c1-d637-11e7-b61d-408d5c5c9416", 
    "deck_configurations": [
        {
            "__type__": "DeckConfig", 
            "autoplay": true, 
            "crowdanki_uuid": "0aecb5c1-d637-11e7-b61d-408d5c5c9416", 
            "dyn": false, 
            "lapse": {
                "delays": [
                    10
                ], 
                "leechAction": 0, 
                "leechFails": 8, 
                "minInt": 1, 
                "mult": 0
            }, 
            "maxTaken": 60, 
            "name": "Default", 
            "new": {
                "bury": true, 
                "delays": [
                    1, 
                    10
                ], 
                "initialFactor": 2500, 
                "ints": [
                    1, 
                    4, 
                    7
                ], 
                "order": 1, 
                "perDay": 20, 
                "separate": true
            }, 
            "replayq": true, 
            "rev": {
                "bury": true, 
                "ease4": 1.3, 
                "fuzz": 0.05, 
                "ivlFct": 1, 
                "maxIvl": 36500, 
                "minSpace": 1, 
                "perDay": 100
            }, 
            "timer": 0
        }
    ], 
    "desc": "", 
    "dyn": 0, 
    "extendNew": 10, 
    "extendRev": 50, 
    "media_files": [], 
    "name": "FRACP", 
    "note_models": [
        {
            "__type__": "NoteModel", 
            "crowdanki_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "css": ".card {\nfont-family: arial;\nfont-size: 16px;\nline-height: 1.4em;\ntext-align: left;\n color: #263238;\n background-color: #ECEFF1;\npadding: 20px;\n}\n\n.card-container{\nbackground-color: white;\npadding: 10px 15px 15px 15px;\nbox-shadow: 0 2px 2px 0 rgba(0,0,0,0.2);\nmargin-bottom: 20px;\nborder-radius: 2px;\n}\n\n.letter{\nfont-size: 20px;\ncolor:#37474F;\nmargin-bottom: 8px;\npadding-bottom: 8px;\nfont-family: Ebrima;\nborder-bottom: 1px solid #388E3C;\n}\n\nul{\n\tlist-style-position: inside;\n\tpadding-left: 0;\npadding-top: 0;\npadding-bottom: 0;\n}\n\n.references{\ncolor: #607D8B;\nfont-size: 14px;\n}", 
            "flds": [
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Question", 
                    "ord": 0, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Answer", 
                    "ord": 1, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Reference", 
                    "ord": 2, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }
            ], 
            "latexPost": "\\end{document}", 
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n", 
            "name": "FRACP Type", 
            "req": [
                [
                    0, 
                    "all", 
                    [
                        0
                    ]
                ]
            ], 
            "sortf": 0, 
            "tags": [
                "Cardiology", 
                "Pharmacology"
            ], 
            "tmpls": [
                {
                    "afmt": "<div class=\"card-container\">\n<div class=\"letter\">Q.</div>\n{{Question}}\n</div>\n\n<div class=\"card-container\">\n<div class=\"letter\">A.</div>\n{{Answer}}\n</div>\n\n<div class=\"card-container references\">\n{{Tags}}\n{{Reference}}\n</div>\n", 
                    "bafmt": "", 
                    "bfont": "Arial", 
                    "bqfmt": "", 
                    "bsize": 12, 
                    "did": null, 
                    "name": "Card 1", 
                    "ord": 0, 
                    "qfmt": "<div class=\"card-container\">\n<div class=\"letter\">Q.</div>\n{{Question}}\n</div>"
                }
            ], 
            "type": 0, 
            "vers": []
        }
    ], 
    "notes": [
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 antianginal medications used in the management of stable angina.", 
                "<ul><li>ß-blockers</li><li>Nitrates</li><li>Calcium channel blockers</li><li>Ranolazine</li></ul>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qz7,uLA)8e", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The COURAGE trial compared PCI + medical therapy vs. medical therapy alone as an initial management strategy in patients with stable angina. What was the main conclusion of this trial?", 
                "Although the addition of PCI to optimal medical therapy reduced the prevalence of angina, it did not reduce long-term rates of death, nonfatal myocardial infarction, and hospitalization for acute coronary syndromes.", 
                "http://www.nejm.org/doi/full/10.1056/NEJMoa070829#t=article"
            ], 
            "flags": 0, 
            "guid": "s(&yGZmQc@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the only antianginal drug class proven to prevent reinfarction and to improve survival in patients who have sustained a myocardial infarction.", 
                "ß-blockers", 
                "https://www.ncbi.nlm.nih.gov/pubmed?term=8371471"
            ], 
            "flags": 0, 
            "guid": "kDEax2q{$r", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name an appropriate first line investigation for suspected stable ischaemic heart disease.", 
                "Cardiac stress testing", 
                ""
            ], 
            "flags": 0, 
            "guid": "qqa`li!;E]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of aspirin.", 
                "Irreversible inhibition of cyclooxygenase and thereby inhibiting the formation of eicosanoids (thromboxane A<sub>2</sub>) via the oxygenation of arachidonic acid.", 
                "https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/215618"
            ], 
            "flags": 0, 
            "guid": "BF>b>hG[t]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The CURE trial tested the efficacy of prolonged aspirin + clopidogrel compared to aspirin alone in ACS without STEMI. What were the key findings?", 
                "<ul><li>Dual antiplatelet therapy was superior to aspirin alone</li><li>20% reduction in nonfatal MI, stroke and cardiovascular death</li><li>18% reduction in evidence of heart failure</li><li>Superiority persisted throughout the 12 month study</li><li>Higher rates of major and minor bleeding, but no increase in life-threatening bleeding or intracranial haemorrhage</li></ul>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kTU/W:~zaZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the recommended time frame in which a patient presenting with acute chest pain or suspected acute coronary syndrome should undergo an ECG?", 
                "10 minutes", 
                "National Heart Foundation of Australia &amp; Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016"
            ], 
            "flags": 0, 
            "guid": "zk:f):Lwzl", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 contraindications to the use of nitrate therapy.", 
                "<ul style=\"margin-left: 20px; \"><li>Allergy</li><li>Hypotension (&lt;90)</li><li>Bradycardia (&lt;50)</li><li>Tachycardia (&gt;100)</li><li>Phosphodiesterase inhibitor within the previous 24 hours</li><li>Hypertrophic cardiomyopathy</li><li>Severe aortic stenosis</li></ul>", 
                "ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction"
            ], 
            "flags": 0, 
            "guid": "iv0T$[op/3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of clopidogrel.", 
                "The active metabolite of the thienopyridines (clopidogrel, prasugrel) irreversibly binds to the platelet P2Y<sub>12</sub>&nbsp;receptor and inhibits platelet aggregation for the life of the platelet.", 
                "Australian Medicines Handbook"
            ], 
            "flags": 0, 
            "guid": "qV]MexO7Dl", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of ticagrelor.", 
                "Ticagrelor <b>reversibly</b> inhibits the adenosine diphosphate (ADP) receptor P2Y<sub>12</sub> ;the thienopyridines (clopidogrel, prasugrel) irreversibly inhibit P2Y<sub>12</sub>.", 
                ""
            ], 
            "flags": 0, 
            "guid": "wf$J875j)7", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The PLATO trial compared ticagrelor and clopidogrel (with both groups receiving aspirin) in patients with acute coronary syndrome, with or without ST-segment elevation. What were the findings of this study?", 
                "", 
                ""
            ], 
            "flags": 0, 
            "guid": "J/Y5?d9ATR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Pharmacology"
            ]
        }
    ]
}